Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20054
20063
20073
20081
20091
20101
20132
20151
20162
20182
20191
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Bristol-Myers Squibb6
Gruppo Italiano Malattie EMatologiche dell'Adulto6
Fred Hutchinson Cancer Center2
Teva Branded Pharmaceutical Products R&D, Inc.2
Ariad Pharmaceuticals1
Associazione Italiana Pazienti Leucemia Mieloide Cronica1
IRCCS San Raffaele1
Pfizer1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive31
Leukemia8
Leukemia, Myeloid, Chronic-Phase5
Blast Crisis4
Philadelphia Chromosome4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Diseases3
Leukemia, Myeloid, Acute3
Bone Marrow Diseases2
Bronchiolitis Obliterans Syndrome2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.